tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
NTLA, PSNL, KMTUY, ILMN: Cathie Wood Buys Early Biotech Stocks, Cuts Stakes in Illumina
PremiumMarket NewsNTLA, PSNL, KMTUY, ILMN: Cathie Wood Buys Early Biotech Stocks, Cuts Stakes in Illumina
1M ago
Personalis: Strengthened Balance Sheet and NeXT Personal Growth Underpin Reiterated Buy Rating and $12 Target
Premium
Ratings
Personalis: Strengthened Balance Sheet and NeXT Personal Growth Underpin Reiterated Buy Rating and $12 Target
1M ago
Accelerating Clinical Adoption and Expanding Medicare Reimbursement Support Buy Rating and Favorable Risk-Reward Profile
Premium
Ratings
Accelerating Clinical Adoption and Expanding Medicare Reimbursement Support Buy Rating and Favorable Risk-Reward Profile
1M ago
Personalis Announces $100M Stock Offering Amendment
PremiumCompany AnnouncementsPersonalis Announces $100M Stock Offering Amendment
3M ago
Personalis Sees Revised Reimbursement Rates for Cancer Tests
Premium
Company Announcements
Personalis Sees Revised Reimbursement Rates for Cancer Tests
3M ago
Personalis price target raised to $9 from $5 at Morgan Stanley
Premium
The Fly
Personalis price target raised to $9 from $5 at Morgan Stanley
3M ago
Personalis Gains Medicare Coverage for Cancer Test
PremiumCompany AnnouncementsPersonalis Gains Medicare Coverage for Cancer Test
3M ago
Personalis announces Medicare coverage of NeXT Personal test
Premium
The Fly
Personalis announces Medicare coverage of NeXT Personal test
3M ago
Personalis price target raised to $10 from $8.50 at H.C. Wainwright
Premium
The Fly
Personalis price target raised to $10 from $8.50 at H.C. Wainwright
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100